植物源流感疫苗的首次人体疗效研究。 - Suppr

Suppr

超能文献

First human efficacy study of a plant-derived influenza vaccine.

作者信息

Tregoning John S

机构信息

Department of Infectious Disease, Imperial College London, St Marys Campus, London W2 1PJ, UK.

出版信息

Lancet. 2020 Nov 7;396(10261):1464-1465. doi: 10.1016/S0140-6736(20)32010-9. Epub 2020 Oct 13.

DOI:10.1016/S0140-6736(20)32010-9

PMID:33065033

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7553753/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f94/7553753/f648cc5fa96a/fx1_lrg.jpg

相似文献

First human efficacy study of a plant-derived influenza vaccine.植物源流感疫苗的首次人体疗效研究。

Lancet. 2020 Nov 7;396(10261):1464-1465. doi: 10.1016/S0140-6736(20)32010-9. Epub 2020 Oct 13.

Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults.一种植物源性重组单价血凝素基流感疫苗（源自甲型 H1N1pdm09 病毒）在健康成年人中的安全性和免疫原性：一项 1 期剂量递增研究。

Vaccine. 2014 Apr 17;32(19):2251-9. doi: 10.1016/j.vaccine.2013.10.017. Epub 2013 Oct 12.

Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials.植物源、四价、类病毒样颗粒流感疫苗在成人（18-64 岁）和老年人（≥65 岁）中的有效性、免疫原性和安全性：两项多中心、随机、3 期临床试验。

Lancet. 2020 Nov 7;396(10261):1491-1503. doi: 10.1016/S0140-6736(20)32014-6. Epub 2020 Oct 13.

Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.针对血凝素：广泛预防甲型流感病毒的方法。

Viruses. 2019 Apr 30;11(5):405. doi: 10.3390/v11050405.

An inactivated subvirion influenza A (H5N1) vaccine.一种灭活亚病毒颗粒甲型流感（H5N1）疫苗。

N Engl J Med. 2006 Jun 22;354(25):2724-5; author reply 2724-5.

Novel universal influenza virus vaccine approaches.新型通用流感病毒疫苗研发方法。

Curr Opin Virol. 2016 Apr;17:95-103. doi: 10.1016/j.coviro.2016.02.002. Epub 2016 Feb 27.

The Influenza Vaccine Mess.流感疫苗乱象

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):178-180. doi: 10.1093/jpids/piy057.

Influenza virus hemagglutinin stalk-based antibodies and vaccines.基于流感病毒血凝素茎部的抗体和疫苗。

Curr Opin Virol. 2013 Oct;3(5):521-30. doi: 10.1016/j.coviro.2013.07.007. Epub 2013 Aug 24.

An inactivated subvirion influenza A (H5N1) vaccine.一种灭活亚病毒颗粒甲型流感（H5N1）疫苗。

N Engl J Med. 2006 Jun 22;354(25):2724-5; author reply 2724-5. doi: 10.1056/NEJMc061152.

In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.对 2016-2017 季节流行的甲型 H3N2 流感病毒血凝素基因的深入系统进化分析揭示了疫苗株的鸡蛋适应性突变。

Expert Rev Vaccines. 2020 Jan;19(1):115-122. doi: 10.1080/14760584.2020.1709827. Epub 2020 Jan 19.

引用本文的文献

Plant-based edible vaccines: Can cholera be the case study in Africa?植物源可食用疫苗：霍乱能成为非洲的案例研究对象吗？

J Genet Eng Biotechnol. 2025 Sep;23(3):100527. doi: 10.1016/j.jgeb.2025.100527. Epub 2025 Jun 23.

Design of Novel Vaccines Based on Virus-Like Particles.基于病毒样颗粒的新型疫苗设计

Subcell Biochem. 2024;105:785-821. doi: 10.1007/978-3-031-65187-8_21.

Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems.探索植物系统中用于治疗性和重组分子的分子农业的最新进展。

Heliyon. 2024 Sep 7;10(18):e37634. doi: 10.1016/j.heliyon.2024.e37634. eCollection 2024 Sep 30.

Development of Fluorescence-Tagged SARS-CoV-2 Virus-like Particles by a Tri-Cistronic Vector Expression System for Investigating the Cellular Entry of SARS-CoV-2.基于三顺反子载体表达系统研制荧光标记 SARS-CoV-2 病毒样颗粒用于研究 SARS-CoV-2 的细胞进入机制

Viruses. 2022 Dec 19;14(12):2825. doi: 10.3390/v14122825.

Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials.四价流感疫苗在成人流感免疫中的应用：一项随机对照试验的系统评价。

Int J Environ Res Public Health. 2022 Aug 1;19(15):9425. doi: 10.3390/ijerph19159425.

Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production.植物源疫苗：抗原设计、多样性及高产策略

Vaccines (Basel). 2022 Jan 10;10(1):100. doi: 10.3390/vaccines10010100.

Integrating plant molecular farming and materials research for next-generation vaccines.整合植物分子农业与材料研究以开发下一代疫苗。

Nat Rev Mater. 2022;7(5):372-388. doi: 10.1038/s41578-021-00399-5. Epub 2021 Dec 6.

Transient protein expression systems in plants and their applications.植物中的瞬时蛋白表达系统及其应用。

Plant Biotechnol (Tokyo). 2021 Sep 25;38(3):297-304. doi: 10.5511/plantbiotechnology.21.0610a.

Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?对抗人类病毒性疾病：植物源疫苗会是答案吗？

Vaccines (Basel). 2021 Jul 8;9(7):761. doi: 10.3390/vaccines9070761.

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.病毒样颗粒：制备、免疫原性及其作为纳米疫苗和药物纳米载体的作用。

J Nanobiotechnology. 2021 Feb 25;19(1):59. doi: 10.1186/s12951-021-00806-7.

本文引用的文献

Lancet. 2020 Nov 7;396(10261):1491-1503. doi: 10.1016/S0140-6736(20)32014-6. Epub 2020 Oct 13.

Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.2017-2018 年美国老年人中细胞培养和鸡蛋基流感疫苗的相对有效性。

J Infect Dis. 2019 Sep 13;220(8):1255-1264. doi: 10.1093/infdis/jiy716.

Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness.2017 - 2018年严重流行季节细胞培养衍生流感疫苗：迈向提高流感疫苗效力的一步。

NPJ Vaccines. 2018 Oct 9;3:44. doi: 10.1038/s41541-018-0079-z. eCollection 2018.

End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.2016/17年英国成人和儿童季末流感疫苗的有效性

Euro Surveill. 2017 Nov;22(44). doi: 10.2807/1560-7917.ES.2017.22.44.17-00306.

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.50 岁及以上成人中重组流感疫苗的效果。

N Engl J Med. 2017 Jun 22;376(25):2427-2436. doi: 10.1056/NEJMoa1608862.

Expression of hepatitis B surface antigen in transgenic plants.乙型肝炎表面抗原在转基因植物中的表达。

Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11745-9. doi: 10.1073/pnas.89.24.11745.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验